Ravi Salgia to Registries
This is a "connection" page, showing publications Ravi Salgia has written about Registries.
Connection Strength
0.260
-
Precision medicine and actionable alterations in lung cancer: A single institution experience. PLoS One. 2020; 15(2):e0228188.
Score: 0.139
-
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer. 2018 01 23; 6(1):8.
Score: 0.121